Gray Foundation Buys 33,179 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Gray Foundation boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 25.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 164,872 shares of the financial services provider’s stock after acquiring an additional 33,179 shares during the period. iShares Biotechnology ETF accounts for 6.2% of Gray Foundation’s investment portfolio, making the stock its 4th largest holding. Gray Foundation’s holdings in iShares Biotechnology ETF were worth $21,798,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets lifted its holdings in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $18,476,000. DRW Securities LLC purchased a new position in iShares Biotechnology ETF in the third quarter valued at approximately $5,990,000. Finally, Erste Asset Management GmbH purchased a new position in iShares Biotechnology ETF in the third quarter valued at approximately $5,678,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $138.74 on Tuesday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company’s 50 day moving average price is $135.64 and its 200 day moving average price is $140.77.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.